Ujvira 160mg Injection

MRP: ₹56245.31 Discount: 48%
Sale Price:

₹29300.00

Add to Cart

Weight/Quantity: 1 VIAL

Store in a refrigerator (2 °C – 8 °C).

Ujvira 160mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. It is used to treat adults with a type of breast cancer (human epidermal growth factor receptor 2 positive breast cancer) that has spread to other parts of the body or has not improved after treatment with other medications. It is a combination of two drugs: trastuzumab, which is a monoclonal antibody that targets HER2-positive breast cancer cells, and emtansine, which is a chemotherapy drug that destroys cancer cells. This medicine is also given after surgery to kill any cancer cells left in the breast (adjuvant therapy). This medication is not recommended for adolescents and children under 18. Before taking this medicine, it is vital to inform your doctor if you have any blood clot disorders, liver disorders, or allergies.

Uses of Ujvira 160mg Injection
Breast cancer

1. Ujvira 160mg Injection shall either be administered before or after surgery.
2. It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious

Heart Problems
Allergic reactions
Kidney problems
Breathing difficulties